Skip to main content
Erschienen in: Wiener Medizinische Wochenschrift 21-22/2015

01.11.2015 | letter to the editor

Sarcoid-like reactions (SLRs) or autonomous sarcoidosis (AS)? Differentiation probably important?

verfasst von: Univ.-Doz. Dr. med. Assoc. Prof. Georgi Tchernev, PhD, Dr. Anastasiya Atanasova Chokoeva, Prof. Uwe Wollina, Prof. Torello Lotti

Erschienen in: Wiener Medizinische Wochenschrift | Ausgabe 21-22/2015

Einloggen, um Zugang zu erhalten

Excerpt

To the Editors,
Literatur
1.
Zurück zum Zitat Baughman RP, Grutters JC. New treatment strategies for pulmonary sarcoidosis: antimetabolites, biological drugs, and other treatment approaches. Lancet Respir Med. 2015. pii:S2213–2600(15)00199–X. doi:10.1016/S2213-2600(15)00199-X. Baughman RP, Grutters JC. New treatment strategies for pulmonary sarcoidosis: antimetabolites, biological drugs, and other treatment approaches. Lancet Respir Med. 2015. pii:S2213–2600(15)00199–X. doi:10.​1016/​S2213-2600(15)00199-X.
2.
Zurück zum Zitat Tchernev G, Chokoeva AA, Schiavone C, Erme A M D, Tana C, Darling M, Kaley J, Gianfaldoni S, Wollina U, Lotti T, Patterson JW. Sarcoidosis exclusion criteria: the “simple truth” for a “complicated diagnosis”. J Biol Regul Homeost Agents. 2015;29(1 Suppl):5–9.PubMed Tchernev G, Chokoeva AA, Schiavone C, Erme A M D, Tana C, Darling M, Kaley J, Gianfaldoni S, Wollina U, Lotti T, Patterson JW. Sarcoidosis exclusion criteria: the “simple truth” for a “complicated diagnosis”. J Biol Regul Homeost Agents. 2015;29(1 Suppl):5–9.PubMed
3.
Zurück zum Zitat Tchernev G, Cardoso JC, Chokoeva AA, Verma SB, Tana C, Ananiev J, Gulubova M, Philipov S, Kanazawa N, Nenoff P, Lotti T, Wollina U. The “mystery” of cutaneous sarcoidosis: facts and controversies. Int J Immunopathol Pharmacol. 2014;27(3):321–30.PubMed Tchernev G, Cardoso JC, Chokoeva AA, Verma SB, Tana C, Ananiev J, Gulubova M, Philipov S, Kanazawa N, Nenoff P, Lotti T, Wollina U. The “mystery” of cutaneous sarcoidosis: facts and controversies. Int J Immunopathol Pharmacol. 2014;27(3):321–30.PubMed
4.
Zurück zum Zitat Vorselaars AD, Verwoerd A, van Moorsel CH, Keijsers RG, Rijkers GT, Grutters JC. Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis. Eur Respir J. 2014;43(2):602–9.CrossRefPubMed Vorselaars AD, Verwoerd A, van Moorsel CH, Keijsers RG, Rijkers GT, Grutters JC. Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis. Eur Respir J. 2014;43(2):602–9.CrossRefPubMed
5.
Zurück zum Zitat Daïen CI, Monnier A, Claudepierre P, Constantin A, Eschard JP, Houvenagel E, Samimi M, Pavy S, Pertuiset E, Toussirot E, Combe B, Morel J; Club Rhumatismes et Inflammation (CRI) Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases. Rheumatology (Oxford). 2009;48(8):883–6.CrossRef Daïen CI, Monnier A, Claudepierre P, Constantin A, Eschard JP, Houvenagel E, Samimi M, Pavy S, Pertuiset E, Toussirot E, Combe B, Morel J; Club Rhumatismes et Inflammation (CRI) Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases. Rheumatology (Oxford). 2009;48(8):883–6.CrossRef
6.
Zurück zum Zitat Drake WP, Oswald-Richter K, Richmond BW, Isom J, Burke VE, Algood H, Braun N, Taylor T, Pandit KV, Aboud C, Yu C, Kaminski N, Boyd AS, King LE Oral antimycobacterial therapy in chronic cutaneous sarcoidosis: a randomized, single-masked, placebo-controlled study. JAMA Dermatol. 2013;149(9):1040–9.PubMedCentralCrossRefPubMed Drake WP, Oswald-Richter K, Richmond BW, Isom J, Burke VE, Algood H, Braun N, Taylor T, Pandit KV, Aboud C, Yu C, Kaminski N, Boyd AS, King LE Oral antimycobacterial therapy in chronic cutaneous sarcoidosis: a randomized, single-masked, placebo-controlled study. JAMA Dermatol. 2013;149(9):1040–9.PubMedCentralCrossRefPubMed
7.
Zurück zum Zitat Drake W, Richmond BW, Oswald-Richter K, Yu C, Isom JM, Worrell JA, Shipl R. Effects of broad-spectrum antimycobacterial therapy on chronic pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2013;30(3):201–11.PubMedCentralPubMed Drake W, Richmond BW, Oswald-Richter K, Yu C, Isom JM, Worrell JA, Shipl R. Effects of broad-spectrum antimycobacterial therapy on chronic pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2013;30(3):201–11.PubMedCentralPubMed
8.
Zurück zum Zitat Tchernev G, Chokoeva AA, Patterson JW, Wollina U, Lotti T. Sarcoid type reaction: medical hypotheses. J Biol Regul Homeost Agents. 2015;29(1 Suppl):35–8.PubMed Tchernev G, Chokoeva AA, Patterson JW, Wollina U, Lotti T. Sarcoid type reaction: medical hypotheses. J Biol Regul Homeost Agents. 2015;29(1 Suppl):35–8.PubMed
Metadaten
Titel
Sarcoid-like reactions (SLRs) or autonomous sarcoidosis (AS)? Differentiation probably important?
verfasst von
Univ.-Doz. Dr. med. Assoc. Prof. Georgi Tchernev, PhD
Dr. Anastasiya Atanasova Chokoeva
Prof. Uwe Wollina
Prof. Torello Lotti
Publikationsdatum
01.11.2015
Verlag
Springer Vienna
Erschienen in
Wiener Medizinische Wochenschrift / Ausgabe 21-22/2015
Print ISSN: 0043-5341
Elektronische ISSN: 1563-258X
DOI
https://doi.org/10.1007/s10354-015-0390-5

Weitere Artikel der Ausgabe 21-22/2015

Wiener Medizinische Wochenschrift 21-22/2015 Zur Ausgabe